Immune checkpoint inhibitors: recent progress and potential biomarkers
<div><p>Cancer growth and progression are associated with immune suppression. Cancer cells have the ability to activate different immune checkpoint pathways that harbor immunosuppressive functions. Monoclonal antibodies that target immune checkpoints provided an immense breakthrough in c...
محفوظ في:
| المؤلف الرئيسي: | Pramod Darvin (153341) (author) |
|---|---|
| مؤلفون آخرون: | Salman M. Toor (8854751) (author), Varun Sasidharan Nair (5396393) (author), Eyad Elkord (5396390) (author) |
| منشور في: |
2018
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
حسب: Said Dermime (79420)
منشور في: (2021) -
Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
حسب: Said Dermime (79420)
منشور في: (2021) -
Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity
حسب: Allan Relecom (14153295)
منشور في: (2021) -
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
حسب: Reem Saleh (3513056)
منشور في: (2019) -
Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
حسب: Reem Saleh (3513056)
منشور في: (2019)